VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
TLSA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
TLSATiziana Life Sciences Ltd
$0.69$44M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksTLSAQuarterly Financials

Tiziana Life Sciences Ltd (TLSA) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Tiziana Life Sciences Ltd (TLSA) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

TLSA Income Statement

Quarterly statement

TLSA Income Statement

Tiziana Life Sciences Ltd (TLSA) annual income statement — 28-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q4'25Q2'25Q4'24Q2'24Q4'23Q2'23Q4'22Q2'22Q4'21Q2'21Q4'20Q2'20Q4'19Q2'19Q4'18Q2'18Q4'17Q2'17Q4'16
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold011.95M09.29M09.29M010.07M0077.77K45.7K44.07K245.47K260.03K7.77K8.25K5.96K4.86K0
COGS % of Revenue--------------------
Gross Profit0-11.95M0-9.29M0-9.29M0-10.07M00-77.77K-45.7K-44.07K-245.47K-260.03K-7.77K-8.25K-5.96K-4.86K0
Gross Margin %--------------------
Gross Profit Growth %--28.63%-0.05%-7.75%--100%100%-76.45%81.38%83.05%-3060%-3051.85%-30.42%-69.72%---
Operating Expenses11.37M09.19M06.51M08.69M04.51M2.25M21.14M25.34M5.06M4.54M4.63M4.75M2.29M1.93M1.79M1.93M
OpEx % of Revenue--------------------
Selling, General & Admin005.94M03.93M05.41M0-2.95M1.47M15.09M5.71M1.96M-1.25M1.24M1.24M-565.82K-430.69K-549K-549K
SG&A % of Revenue--------------------
Research & Development6.43M03.24M02.58M03.29M07.46M3.73M6.05M2.8M469.04K1.86M1.84M1.84M2.85M2.17M2.34M2.34M
R&D % of Revenue--------------------
Other Operating Expenses1000K00000000-1000K01000K1000K1000K1000K1000K0187.53K0147.5K
Operating Income-11.37M-11.95M-9.19M-9.29M-6.51M-9.29M-8.69M-10.07M-4.51M-5.2M-21.22M-25.38M-5.11M-4.98M-4.93M-4.92M-5.14M-3.91M-4.12M-4.12M
Operating Margin %--------------------
Operating Income Growth %-23.82%-28.63%-41.17%0.05%25.14%7.75%-92.6%-93.56%78.73%79.5%-315.3%-409.5%-3.72%-1.19%4.16%-25.85%-24.65%5.12%-13.14%-75%
EBITDA-11.22M-11.8M-9.1M-9.22M-6.45M-9.25M-8.64M-10.03M-4.51M-5.2M-21.14M-25.34M-5.06M-4.85M-4.8M-4.8M-5.13M-3.91M-4.12M-4.12M
EBITDA Margin %--------------------
EBITDA Growth %-23.28%-27.91%-41.16%0.28%25.38%7.74%-91.59%-92.77%78.67%79.47%-317.38%-421.87%-5.51%-1.19%6.45%-22.84%-24.62%5.14%-13.12%-
D&A (Non-Cash Add-back)158K146K88K62K62K41K55K46K5K2.5K77.77K45.7K44.07K126.89K125.47K125.4K8.28K6.3K5.5K5.5K
EBIT-12.39M-12.8M-5.63M-8.76M-7.98M-8.62M-8.61M-10.88M-4.51M-5.2M-21.22M-25.38M-5.11M-4.98M-4.93M-4.92M-5.14M-3.91M-4.12M-4.12M
Net Interest Income005K696K112K1.15M-5K-7K0-56-25K-310.77K-6.3K-84.34K-6.47K-6.47K-5.5K-4.96K-3.89K-8.5K
Interest Income005K702K112K1.15M000007.83K01.26K000000
Interest Expense0006K05K5K7K0025K318.6K6.3K85.6K6.47K6.47K5.5K4.96K3.89K4.5K
Other Income/Expense-1.01M-853K3.55M521K-1.47M667K75K-811K02743.74M1.7M154.89K-46.78K-46.26K-46.23K-5.69K-4.33K-4.5K-4.5K
Pretax Income-12.39M-12.8M-5.63M-8.77M-7.98M-8.63M-8.62M-10.88M-4.51M-4.83M-17.48M-23.68M-4.95M-5.03M-4.97M-4.97M-5.15M-3.92M-4.13M-4.13M
Pretax Margin %--------------------
Income Tax000-1.56M-3.33M449K00000-2.24M0-346.08K-342.2K-342.01K-1.01M-766.8K-742.5K-742.5K
Effective Tax Rate %0%0%0%17.76%41.68%-5.21%0%0%0%0%0%9.48%0%6.88%6.88%6.88%19.58%19.58%17.99%17.99%
Net Income-12.39M-12.8M-5.63M-7.21M-4.65M-9.07M-8.62M-10.88M-4.51M-3.21M-17.48M-21.43M-4.95M-4.68M-4.63M-4.63M-4.14M-3.15M-3.38M-3.38M
Net Margin %--------------------
Net Income Growth %-119.94%-77.54%-21.01%20.55%45.99%16.63%-90.94%-239.25%74.18%85.03%-252.85%-357.73%-7%-1.19%-11.89%-46.92%-22.24%6.96%6.08%14.52%
Net Income (Continuing)-12.39M-12.8M-5.63M-7.21M-4.65M-9.07M-8.62M-10.88M-4.51M-3.21M-17.48M-21.43M-4.95M-4.68M-4.63M-4.63M-4.14M-3.15M-3.38M-3.38M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.10-0.11-0.05-0.07-0.05-0.09-0.08-0.11-0.05-28.90-0.24-0.24-0.07-0.07-0.07-0.07-0.06-0.05-0.06-0.06
EPS Growth %-101.04%-63.7%-6.87%25.35%43.63%17.4%-64.61%99.63%79.75%-11941.67%-263.64%-250.88%2.94%-0.89%-5.26%-37.8%-1.57%22.64%17.62%26.05%
EPS (Basic)-0.10-0.11-0.05-0.07-0.05-0.09-0.08-0.11-0.05-28.90-0.24-0.24-0.07-0.07-0.07-0.07-0.06-0.05-0.06-0.06
Diluted Shares Outstanding127.87M118.28M116.83M106.67M103.1M102.47M102.27M101.53M97.93M110.82M75.11M44.39M75.11M68.24M68.24M68.24M63.78M63.78M53.2M53.2M
Basic Shares Outstanding127.87M118.28M116.83M106.67M103.1M102.47M102.27M101.53M97.93M110.82M75.11M44.39M75.11M68.24M68.24M68.24M63.78M63.78M53.2M53.2M
Dividend Payout Ratio--------------------